| Drug Name: | Naphazoline (835-31-4) |
|---|---|
| PubChem ID: | 4436 |
| SMILES: | C1CN=C(N1)CC2=CC=CC3=CC=CC=C32 |
| InchiKey: | CNIIGCLFLJGOGP-UHFFFAOYSA-N |
| Therapeutic Category: | Adrenergic Agents, Adrenergic Agonists, Adrenergic alpha-Agonists, Cardiovascular Agents, Nasal Decongestants, Neurotransmitter Agents, Respiratory System Agents, Vasoconstrictor Agents |
| Molecular Weight (dalton) | : | 210.28 |
| LogP | : | 2.384 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 2 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 24.39 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category